Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
暂无分享,去创建一个
J. Utikal | C. Berking | A. Hauschild | D. Schadendorf | C. Garbe | J. Simon | C. Loquai | P. Terheyden | L. Zimmer | R. Stadler | E. Kämpgen | P. Mohr | F. Kiecker | T. Eigentler | E. Dippel | R. Rompel | M. Fluck | Zeinab Assi